Ерибулин Адвц

Eribulin Mesylate is a chemotherapy medication used for cancer treatment. It belongs to the microtubule inhibitor class and is administered intravenously. This page provides neutral, factual information about its uses, effects, and handling.

Eribulin Mesylate is primarily used to treat certain types of cancer, including metastatic breast cancer and liposarcoma. It works by stopping cancer cells from dividing and spreading. Patients often ask, 'what is Eribulin Mesylate used for' to understand its role in treatment plans. It is prescribed when other treatments have not been effective.

Eribulin Mesylate may cause side effects such as fatigue, nausea, or hair loss. Some patients experience changes in blood cell counts, which can increase infection risk. These effects vary by individual and should be monitored by a healthcare provider. Regular check-ups help manage any discomfort.

Eribulin Mesylate should only be handled and administered by healthcare professionals. Patients must inform their doctor about all medications and medical conditions before starting treatment. Avoid exposure to infections and stay hydrated. Follow all safety guidelines provided by your healthcare team.

Eribulin Mesylate can interact with other drugs, including CYP3A4 inhibitors or inducers, which may affect its effectiveness. Alcohol and certain supplements may also interact. Always disclose all medications, including over-the-counter and herbal products, to your doctor. This helps prevent potential complications.